We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPH icon
151
Enphase Energy
ENPH
$5.01B
$24.7M 0.16%
134,953
-19,558
-13% -$4.08M
FTNT icon
152
Fortinet
FTNT
$112B
$24.3M 0.16%
338,615
+190,415
+128% +$12.5M
BMRN icon
153
BioMarin Pharmaceuticals
BMRN
$11.6B
$24.2M 0.15%
274,207
-2,000
-0.7% -$165K
HPQ icon
154
HP
HPQ
$24.3B
$24M 0.15%
637,844
-78,075
-11% -$2.55M
SYF icon
155
Synchrony
SYF
$24.5B
$24M 0.15%
517,761
+191,911
+59% +$9.23M
CL icon
156
Colgate-Palmolive
CL
$73.6B
$24M 0.15%
280,848
-26,568
-9% -$2.07M
CYTK icon
157
Cytokinetics
CYTK
$10.9B
$23.4M 0.15%
513,344
– –
AMRC icon
158
Ameresco
AMRC
$1.12B
$23.3M 0.15%
286,582
-86,057
-23% -$6.88M
NRIX icon
159
Nurix Therapeutics
NRIX
$2.43B
$23M 0.15%
794,103
+239,107
+43% +$7.25M
HASI icon
160
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$22.7M 0.15%
427,769
– –
CRWD icon
161
CrowdStrike
CRWD
$183B
$22.7M 0.14%
443,468
+405,724
+1,075% +$24.7M
HLT icon
162
Hilton Worldwide
HLT
$75.3B
$22.5M 0.14%
144,041
-11,341
-7% -$1.63M
CMG icon
163
Chipotle Mexican Grill
CMG
$42.6B
$22.2M 0.14%
634,750
+23,250
+4% +$819K
MSI icon
164
Motorola Solutions
MSI
$70.3B
$22.1M 0.14%
81,280
+47,301
+139% +$11.9M
XOM icon
165
ExxonMobil
XOM
$642B
$22M 0.14%
360,127
-19,499
-5% -$1.22M
ALGN icon
166
Align Technology
ALGN
$12B
$22M 0.14%
33,464
+4,108
+14% +$2.64M
NEE icon
167
NextEra Energy
NEE
$185B
$21.6M 0.14%
231,140
-129,721
-36% -$11.2M
CRNC icon
168
Cerence
CRNC
$375M
$21.5M 0.14%
281,048
+53,520
+24% +$4.72M
BASE
169
DELISTED
Couchbase
BASE
$21.4M 0.14%
+858,038
New +$28.3M
NUE icon
170
Nucor
NUE
$56.4B
$20.9M 0.13%
179,626
+13,321
+8% +$1.46M
KLAC icon
171
KLA
KLAC
$266B
$20.9M 0.13%
485,330
-22,410
-4% -$865K
UPS icon
172
United Parcel Service
UPS
$96B
$20.8M 0.13%
97,181
+4,228
+5% +$860K
HST icon
173
Host Hotels & Resorts
HST
$17.1B
$20.6M 0.13%
1,183,611
+1,114,537
+1,614% +$18.8M
NFLX icon
174
Netflix
NFLX
$293B
$20.5M 0.13%
339,780
-21,840
-6% -$1.4M
ATVI
175
DELISTED
Activision Blizzard
ATVI
$20.4M 0.13%
306,944
-320,373
-51% -$21.9M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.